Conference championship weekend delivered, and now we all wait for the final rankings from the College Football Playoff selection committee. One thing that won't be up for grabs is which team will ...

NFL Week 12 may have been the most exciting week of the season so far. At least eight games were settled by one score or less – even from the start with the Houston Texans’ stunning victory over the ...

Sunday was a remarkable day in the NFL. With a loaded slate full of intriguing matchups, everyone knew Week 11 was going to be magical, and it sure delivered. In the 1 p.m. slate, Bryce Young threw ...

The Indianapolis Colts defeated the Atlanta Falcons in a 31-25 win to kick off Week 10 from Olympiastadion in Berlin. In the early window, the Ravens stayed hot with a 27-19 win over the Vikings and ...

There was plenty of action and some big time highlights that went down last night. Let's take a look at what you might have missed from the late window: No. 3 Texas A&M 49, No. 20 LSU 25 No. 3 Texas A ...

DIII Curry College running back Montie Quinn made headlines on Saturday for his record-breaking day against Nichols. He rushed for 522 yards on 20 carries with seven touchdowns. Yes, 522. The rushing ...

Abstract: Post-click conversion rate (CVR) is a reliable indicator of online customers’ preferences, making it crucial for developing recommender systems. A major challenge in predicting CVR is severe ...

LOUISVILLE, Ky. (WDRB) -- After decades of fighting compensation for college athletes, and years of courtroom losses, the NCAA and its most powerful conferences may be on the verge of winning ...

A decade-long slide in high schoolers’ reading and math performance persisted during the COVID-19 pandemic, with 12th graders’ scores dropping to their lowest level in more than 20 years, according to ...

A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...

Final analysis of fixed-duration ibrutinib + venetoclax for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in the phase 2 CAPTIVATE study. Preliminary safety and efficacy data of ...